Molecular targeted drugs resistance impairs double-strand break repair and sensitizes ER-positive breast cancer to PARP inhibitors

被引:0
|
作者
Yuna Suzuki
Wu Wenwen
Tomohiko Ohta
Shin-ichi Hayashi
机构
[1] Tohoku University,Department of Molecular and Functional Dynamics, Graduate School of Medicine
[2] St. Marianna University Graduate School of Medicine,Department of Translational Oncology
来源
Breast Cancer | 2022年 / 29卷
关键词
Breast cancer; DNA repair; CDK4/6 inhibitor; PARP inhibitor; Drug resistance;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:77 / 91
页数:14
相关论文
共 50 条
  • [21] ER stress suppresses DNA double-strand break repair and sensitizes tumor cells to ionizing radiation by stimulating proteasomal degradation of Rad51
    Yamamori, Tohru
    Meike, Shunsuke
    Nagane, Masaki
    Yasui, Hironobu
    Inanami, Osamu
    FEBS LETTERS, 2013, 587 (20) : 3348 - 3353
  • [22] A fine-scale dissection of the DNA double-strand break repair machinery and its implications for breast cancer therapy
    Liu, Chao
    Srihari, Sriganesh
    Cao, Kim-Anh Le
    Chenevix-Trench, Georgia
    Simpson, Peter T.
    Ragan, Mark A.
    Khanna, Kum Kum
    NUCLEIC ACIDS RESEARCH, 2014, 42 (10) : 6106 - 6127
  • [23] Influence of Double-Strand Break Repair on Radiation Therapy-Induced Acute Skin Reactions in Breast Cancer Patients
    Mumbrekar, Kamalesh Dattaram
    Fernandes, Donald Jerard
    Goutham, Hassan Venkatesh
    Sharan, Krishna
    Vadhiraja, Bejadi Manjunath
    Satyamoorthy, Kapaettu
    Sadashiva, Satish Rao Bola
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 88 (03): : 671 - 676
  • [24] Dynamic surveillance of tamoxifen-resistance in ER-positive breast cancer by CAIX-targeted ultrasound imaging
    Li, Ying
    Chen, Xiaoyu
    Zhou, ZhiWei
    Li, Qing
    Westover, Kenneth D.
    Wang, Meng
    Liu, Junjun
    Zhang, Sheng
    Zhang, Jin
    Xu, Bo
    Wei, Xi
    CANCER MEDICINE, 2020, 9 (07): : 2414 - 2426
  • [25] CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair
    Shenoy, T. R.
    Boysen, G.
    Wang, M. Y.
    Xu, Q. Z.
    Guo, W.
    Koh, F. M.
    Wang, C.
    Zhang, L. Z.
    Wang, Y.
    Gil, V.
    Aziz, S.
    Christova, R.
    Rodrigues, D. N.
    Crespo, M.
    Rescigno, P.
    Tunariu, N.
    Riisnaes, R.
    Zafeiriou, Z.
    Flohr, P.
    Yuan, W.
    Knight, E.
    Swain, A.
    Ramalho-Santos, M.
    Xu, D. Y.
    de Bono, J.
    Wu, H.
    ANNALS OF ONCOLOGY, 2017, 28 (07) : 1495 - 1507
  • [26] DNA replication licensing is associated with resistance to CDK4/6 inhibitors in ER-positive breast cancer
    Nanda, Sarmistha
    Shea, Martin J.
    Schiff, Rachel
    Osborne, C. Kent
    Rimawi, Mothaffar
    Fu, Xiaoyong
    CANCER RESEARCH, 2023, 83 (05)
  • [27] The DNA double-strand break repair genes BARD1 and RAD51 as molecular targets for brain metastases from breast cancer
    Woditschka, Stephan
    Palmieri, Diane
    Flores, Natasha M.
    Sledge, George W.
    Badve, Sunil
    Steeg, Patricia S.
    CANCER RESEARCH, 2011, 71
  • [28] Targeting mTOR to overcome resistance to hormone and CDK4/6 inhibitors in ER-positive breast cancer models
    María Jimena Rodriguez
    María Cecilia Perrone
    Marina Riggio
    Marta Palafox
    Valeria Salinas
    Andrés Elia
    Natali Daiana Salgueiro
    Andrea Eugenia Werbach
    María Paula Marks
    Marcelo A. Kauffman
    Luciano Vellón
    Violeta Serra
    Virginia Novaro
    Scientific Reports, 13
  • [29] Targeting mTOR to overcome resistance to hormone and CDK4/6 inhibitors in ER-positive breast cancer models
    Rodriguez, Maria Jimena
    Perrone, Maria Cecilia
    Riggio, Marina
    Palafox, Marta
    Salinas, Valeria
    Elia, Andres
    Salgueiro, Natali Daiana
    Werbach, Andrea Eugenia
    Marks, Maria Paula
    Kauffman, Marcelo A.
    Vellon, Luciano
    Serra, Violeta
    Novaro, Virginia
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [30] Combination of ZEN-3694 with CDK4/6 inhibitors reverses resistance in ER-positive breast cancer
    Kharenko, Olesya A.
    Patel, Reena G.
    Calosing, Cyrus
    van der Horst, Edward H.
    CANCER RESEARCH, 2020, 80 (16)